Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
NCT06972875
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Prostate CA
Androgen Deprivation Therapy
Interventions
DRUG:
Fezolinetant
Sponsor
University of Vermont